CMI launches a new brand platform, website

Full-service marketing research firm CMI has launched a new brand platform that focuses on the company's ability to impact clients' business.

The rebranding effort includes a new tagline—“Relevant research that drives results”—and a new website, www.cmiresearch.com. According to Angela Wells, VP, sales and marketing, CMI tweaked internal operations in keeping with the new brand. “We have formed a new client services team, and as a result, all of our account management and project management teams—approximately one-third of the company—now report into the SVP of business strategy,” said Wells. “By combining these two [previously separate] groups, we believe we will be able to satisfy our client needs quicker and with fewer procedures. This new team focuses our efforts on our clients' results, regardless of the functional role of our employees who service the clients.”

In addition to Sciele Pharmaceuticals, Kaiser Permanente, Capital Blue Cross and others, CMI works with “one of the nation's leading pharmaceutical companies, with several brands over $1 billion in annual sales,” said Wells. “We also work with one of the largest generic drug manufacturers.”

CMI, based in Atlanta, has 43 employees, with satellite offices in New York, North Carolina, Iowa and Colorado. The company's new brand was developed through a partnership with Atlanta-based MAX20.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.